Molecular Metabolism LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept Coskun T, Sloop KW, Loghin C, et al
Research shows GLP-1 medications may help reduce cravings and prevent relapse
Branched Chain Amino Acids (BCAAs) stimulate protein synthesis, promote muscle growth, help reduce the breakdown of muscle cells, and minimize muscle fatigue, soreness, and recovery time.
BMI above 30 PPO Requirements: Pre-authorization Higher need for the medication Medical necessity (Labs, Clinical History, Medical Records) BMI of 27 or more with a cardiovascular risk BMI of 30 or more without cardiovascular risk Documentation of participation in lifestyle intervention consisting of reduced calorie diet, increased physical activity and behavioral modification for 6 months within the last year Some insurances might need BMI above 40 HMO Requirements: May use health carrier plan or pharmacy insurance May require prior authorization Medical necessity (Labs, Clinical History, Medical Records) Insurance Disclaimer (California) GLP-1 medications may not be covered by all California insurance plans
Do not use for weight reduction
